Circulating dipeptidyl peptidase (cDPP3)-A marker for end-stage heart failure?

J Intern Med. 2022 Jun;291(6):886-890. doi: 10.1111/joim.13449. Epub 2022 Jan 10.

Authors

Noemi Pavo¹, Suriya Prausmüller¹, Georg Spinka¹, Georg Goliasch¹, Philipp E Bartko¹, Henrike Arfsten¹, Karine Santos², Guido Strunk³, Martin Hülsmann¹

Affiliations

¹ Department of Internal Medicine II, Clinical Division of Cardiology, Medical University of Vienna, Vienna, Austria.
² 4TEEN4 Pharmaceuticals GmbH, Hennigsdorf, Germany.
³ Complexity Research, Vienna, Austria; FH Campus Vienna, Vienna, Austria and Technical University Dortmund, Dortmund, Germany.

No abstract available

Keywords: angiotensin; angiotensin-receptor-neprilysin-inhibition (ARNI); heart failure; renin; renin-angiotensin system (RAS).

Publication types

Letter

MeSH terms

Angiotensin Receptor Antagonists
Drug Combinations
Heart Failure* / diagnosis
Humans
Neprilysin
Peptidyl-Dipeptidase A*
Stroke Volume

Substances

Angiotensin Receptor Antagonists
Drug Combinations
Peptidyl-Dipeptidase A
Neprilysin